GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS AS ANTI-CANCER AGENTS
申请人:ADVANOMICS CORPORATION
公开号:US20150353573A1
公开(公告)日:2015-12-10
The present document describes a synthesis of a class of gem-difluorinated C-glycoside compounds derived from podophyllotoxin, which may be used, but not exclusively, in oncology for the treatment of cancer. More particularly, the podophyllotoxin gem-difluorinated C-glycoconjugated derivatives display improved conformational and chemical stability, and improved cytotoxicity exhibited against drug-resistant cancer cell lines.
PROCESS FOR PREPARING GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS
申请人:Advanomics Corp.
公开号:EP3530663A1
公开(公告)日:2019-08-28
The present invention concerns the synthesis of a class of gem-difluorinated C-glycoside compounds derived from podophyllotoxin which may be used, but not exclusively, in oncology for the treatment of cancer.
Gem-difluorinated C-glycoside compounds as anti-cancer agents
申请人:ADVANOMICS CORPORATION
公开号:US10272065B2
公开(公告)日:2019-04-30
The present document describes a synthesis of a class of gem-difluorinated C-glycoside compounds derived from podophyllotoxin, which may be used, but not exclusively, in oncology for the treatment of cancer. More particularly, the podophyllotoxin gem-difluorinated C-glycoconjugated derivatives display improved conformational and chemical stability, and improved cytotoxicity exhibited against drug-resistant cancer cell lines.
[EN] GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS AS ANTI-CANCER AGENTS<br/>[FR] COMPOSÉS C-GLYCOSIDES GEM-DIFLUORÉS EN TANT QU'AGENTS ANTICANCÉREUX
申请人:ADVANOMICS CORP
公开号:WO2014107803A1
公开(公告)日:2014-07-17
The present document describes a synthesis of a class of gem-difluorinated C-glycoside compounds derived from podophyllotoxin, which may be used, but not exclusively, in oncology for the treatment of cancer. More particularly, the podophyllotoxin gem-difluorinated C-glycoconjugated derivatives display improved conformational and chemical stability, and improved cytotoxicity exhibited against drug-resistant cancer cell lines.